Ectopic ACTH syndrome: Our experience with 25 cases

European Journal of Endocrinology

Volumn 155, Issue 5, 2006, Pages 725-733

  Salgado, Luiz Roberto ^a   Fragoso, Maria Candida Barisson Vilares ^a   Knoepfelmacher, Mirta ^a   Machado, Marcio Carlos ^a   Domenice, Sorahia ^a   Pereira, Maria Adelaide Albergaria ^a   de Mendonça, Berenice Bilharinho ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DESMOPRESSIN; DEXAMETHASONE; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; HYDROCORTISONE; KETOCONAZOLE; OCTREOTIDE; PENTETREOTIDE IN 111;

ADOLESCENT; ADRENALECTOMY; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BRAIN SCINTISCANNING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEATH; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG RESPONSE; ECTOPIC CORTICOTROPIN PRODUCTION; FEMALE; HUMAN; HYPERCORTISOLISM; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROGNOSIS; THORAX TUMOR;

EID: 33845238307     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02278     Document Type: Article

References (57)

1. Brown WH. A case of pluriglandular syndrome: diabetes of bearded women. Lancet 1928 2 1022-1023.
2. Leyton O, Turnball AM & Bratton AB. Cancer of thymus. Journals of Pathology and Bacteriology 1931 34 635-660.
3. Terzolo M, Reimondo G, Ali A, Bovio S, Daffara F, Paccotti P & Angeli A. Ectopic ACTH syndrome: molecular bases and clinical heterogeneity. Annals of Oncology 2001 12 S83-S87.
4. Newell-Price J. Proopiomelanocortin gene expression and DNA methylation: implications for Cushing's syndrome and beyond. Journal of Endocrinology 2003 177 365-372.
5. Baylin SB & Mendelsohn G. Ectopic (inappropriate) hormone production by tumors: mechanisms involved and the biological and clinical implications. Endocrine Reviews 1980 1 45-77.
6. Wajchenberg BL, Mendonca BB, Liberman B, Pereira MA, Carneiro PC, Wakamatsu A & Kirschner MA. Ectopic adrenocorticotropic hormone syndrome. Endocrine Reviews 1994 15 752-787.
7. Beuschlein F & Hammer GD. Ectopic pro-opiomelanocortin syndrome. Endocrinology and Metabolism Clinics of North America 2002 31 191-234.
8. Becker M & Aron DC. Ectopic AM syndrome and CRH-mediated Cushing's syndrome. Endocrinology and Metabolism Clinics of North America 1994 23 585-606.
9. Stewart PM, Walker BR, Holder G, O'Halloran D & Shackleton CH. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. Journal of Clinical Endocrinology and Metabolism 1995 80 3617-3620.
10. Arteaga E, Fardella C, Campusano C, Cardenas I & Martinez P. Persistent hypokalemia after successful adrenalectomy in a patient with Cushing's syndrome due to ectopic ACTH secretion: possible role of 11beta-hydroxysteroid dehydrogenase inhibition. Journal of Endocrinological Investigation 1999 22 857-859.
11. Silber RH & Porter CC. The determination of 17,21-dihydroxi-20-ketosteroids in urine and plasma. Journal of Biological Chemistry 1954 210 923-932.
12. Raff H. Salivary cortisol a useful measurement in the diagnosis of Cushing's syndrome and the evaluation of the hypothalamic-pituitary-adrenal axis. The Endocrinologist 2000 10 9-17.
13. Liddle GW, Island DP, Ney RL, Nicholson WE & Shimizu N. Nonpituitary neoplasms and Cushing's syndrome, ectopic 'adrenocorticotropin' produced by nonpituitary neoplasms as a cause of Cushing's syndrome. Archives of Internal Medicine 1963 111 471-475.
14. Kaye TB & Crapo L. Cushing syndrome: an update on diagnostic tests. Annals of Internal Medicine 1990 112 433-444.
15. Raff H & Findling JW. A new immunoradiometric assay for corticotrophin evaluated in normal subjects and patients with Cushing's syndrome. Clinical Chemistry 1989 35 596-600.
16. Crapo L. Cushing's syndrome: a review of diagnostic tests. Metabolism 1979 28 955-977.
17. Malerbi DA, Mendonca BB, Liberman B, Toledo SP, Corradini MC, Cunha-Neto MB, Fragoso MC & Wajchenberg BL. The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome. Clinical Endocrinology 1993 38 463-472.
18. Terzolo M, Reimondo G & Angeli A. Desmopressin test in mild Cushing syndrome. Archives of Internal Medicine 2003 163 850-851.
19. Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL & Cutler GB, Jr. A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1993 77 1308-1312.
20. Newell-Price J, Morris DG, Drake WM, Korbonits M, Monson JP, Besser GM & Grossman AB. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2002 87 1640-1645.
21. Orth DN, DeBold CR, DeCherney GS, Jackson RV, Alexander AN, Rivier J, Rivier C, Spiess J & Vale W. Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor. Journal of Clinical Endocrinology and Metabolism 1982 55 1017-1019.
22. Newell-Price J, Trainer P, Besser M & Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocrine Reviews 1998 19 647-672.
23. Tabarin A, San Galli F, Dezou S, Leprat F, Corcuff JB, Latapie JL, Guerin J & Roger P. The corticotropin-releasing factor test in the differential diagnosis of Cushing's syndrome: a comparison with the lysine-vasopressin test. Acta Endocrinologica 1990 123 331-338.
24. Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G & Camanni F. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1997 82 2439-2444.
25. Oliveira JH, Vieira JG, Abucham J & Lengyel AM. GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP. Journal of Endocrinological Investigation 2003 26 205-230.
26. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler GB, Jr & Loriaux DL. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. New England Journal of Medicine 1991 325 897-905.
27. Lefournier V, Martinie M, Vasdev A, Bessou P, Passagia JG, Labat-Moleur F, Sturm N, Bosson JL, Bachelot I & Chabre O. Accuracy of bilateral inferior petrosal or cavernous sinuses sampling in predicting the lateralization of Cushing's disease pituitary microadenoma: influence of catheter position and anatomy of venous drainage. Journal of Clinical Endocrinology and Metabolism 2003 88 196-203.
28. Findling JW, Kehoe ME, Shaker JL & Raff H. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome. Journal of Clinical Endocrinology and Metabolism 1991 73 408-413.
29. Salgado LR, Mendonça BB, Pereira MAA, Goic MSZ, Semer M, Moreira AC, Knoepfelmacher M, Nery M, Magalhaes ACA, Tovo R, Wajchenberg BL & Liberman B. Use of desmopressin in bilateral and simultaneous inferior petrosal sinus sampling for differential diagnosis of ACTH-dependent Cushing's syndrome. The Endocrinologist 1997 7 135-140.
30. Le Rest C, Bomanji JB, Costa DC, Townsend CE, Visvikis D & Ell PJ. Functional imaging of malignant paragangliomas and carcinoid tumours. European Journal of Nuclear Medicine 2001 28 478-482.
31. 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. European Journal of Nuclear Medicine 1998 25 1255-1260.
32. Pacak K, Illias I, Chen CC, Carrasquillo JA, Whatley M & Nieman LK. The role of [(18)F] fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 2214-2221.
33. Torpy DJ, Chen CC, Mullen N, Doppman JL, Carrasquillo JA, Chrousos GP & Nieman LK. Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients. Journal of Clinical Endocrinology and Metabolism 1999 84 1186-1192.
34. Sonino N, Boscaro M, Merola G & Mantero F. Prolonged treatment of Cushing's disease by ketoconazole. Journal of Clinical Endocrinology and Metabolism 1985 61 718-722.
35. Hearn PR, Reynolds CL, Johansen K & Woodhouse NJ. Lung carcinoid with Cushing's syndrome: control of serum ACTH and cortisol levels using SMS 201-995 (sandostatin). Clinical Endocrinology 1988 28 181-185.
36. 111In-DTPA-D-Phe1]-octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment. Clinical Endocrinology 1998 48 303-309.
37. Howlett TA, Drury PL, Perry L, Doniach I, Rees LH & Besser GM. Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clinical Endocrinology 1986 24 699-713.
38. Shepherd FA, Laskey J, Evans WK, Goss PE, Johansen E & Khamsi F. Cushing's syndrome associated with ectopic corticotropin production and small-cell lung cancer. Journal of Clinical Oncolooy 1992 10 21-27.
39. Mendonca BB, Arnhold IJ, Nicolau W, Avancini VA & Bloise W. Cushing's syndrome due to ectopic ACTH secretion by bilateral pheochromocytomas in multiple endocrine neoplasia type 2A. New England Journal of Medicine 1988 319 1610-1611.
40. Mendonca BB, Madureira G, Bloise W, Albergaria A, Halpern A, Liberman B, Villares SM, Batista MC, Avancini VF & Nitterdorfi CT. Cushing syndrome due to ectopic ACTH secretion. Revista Paulista Medicina 1989 107 29-36.
41. Pass HI, Doppman JL, Nieman L, Stovroff M, Vetto J, Norton JA, Travis W, Chrousos GP, Oldfield EH & Cutler GB, Jr. Management of the ectopic ACTH syndrome due to thoracic carcinoids. Annals of Thoracic Surgery 1990 50 52-57.
42. Imura H. Ectopic hormone syndromes. Clinical Endocrinology and Metabolism 1980 9 235-260.
43. Isidori AM, Kaltsas GA, Pozza C, Fragese V, Newell-Price J, reznek RH, Jenkins P, Monson JP, Grossman AB & Besser M. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. Journal of Clinical Endocrinology and Metabolism 2006 91 371-377.
44. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley A & Nieman L. Cushing's syndrome due to ectopic corticotrpin secretion: twenty years' experience at the National Institutes of Health. Journal of Clinical Endocrinology and Metabolism 2005 90 4955-4962.
45. Aron DC, Raff H & Findling JW. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1997 82 1780-1785.
46. Flack MR, Oldfield EH, Cutler GB, Jr, Zweig MH, Malley JD, Chrousos GP, Loriaux DL & Nieman LK. Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. Annals of Internal Medicine 1992 116 211-217.
47. Vale W, Spiess J, Rivier C & Rivier J. Characterization of a 41-residue ovine hyphothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981 213 1394-1397.
48. de Keyzer Y, Lenne F, Auzan C, Jegou S, Rene P, Vaudry H, Kuhn JM, Luton JP, Clauser E & Bertagna X. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. Journal of Clinical Investigation 1996 97 1311-1318.
49. Lindsay JR & Nieman LK. Differential diagnosis and imaging in Cushing's syndrome. Endocrinology and Metabolism Clinics of North America 2005 34 403-421.
50. Yamamoto Y, Davis DH, Nippoldt TB, Young WF, Jr, Huston J, III & Parisi JE. False-positive inferior petrosal sinus sampling in the diagnosis of Cushing's disease. Report of two cases. Journal of Neurosurgical 1995 83 1087-1091.
51. Belsky JL, Cuello B, Swanson LW, Simmons DM, Jarrett RM & Braza F. Cushing's syndrome due to ectopic production of corticotropin-releasing factor. Journal of Clinical Endocrinology and Metabolism 1985 60 496-500.
52. Carey RM, Varma SK, Drake CR, Jr, Thorner MO, Kovacs K, Rivier J & Vale W. Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study. New England Journal of Medicine 1984 311 13-20.
53. Swearingen B, Katznelson L, Miller K, Grinspoon S, Waltman A, Dorer DJ, Klibanski A & Biller BM. Diagnostic errors after inferior petrosal sinus sampling. Journal of Clinical Endocrinology and Metabolism 2004 89 3752-3763.
54. Shrager JB, Wright CD, Wain JC, Torchiana DF, Grillo HC & Mathisen DJ. Bronchopulmonary carcinoid tumors associated with Cushing's syndrome: a more aggressive variant of typical carcinoid. Journal of Thoracic and Cardiovascular Surgery 1997 114 367-375.
55. Doppman JL, Pass HI, Nieman LK, Findling JW, Dwyer AJ, Feuerstein IM, Ling A, Travis WD, Cutler GB, Jr & Chrousos GP. Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs CT. American Journal of Roentgenology 1991 156 39-43.
56. De Herder WW & Lamberts SW. Octapeptide somatostatin-analogue therapy of Cushing's syndrome. Postgraduate Medical Journal 1999 75 65-66.
57. Heath H, Edis A, Maton PN, Gardner JD & Jensen RT. Cushing's syndrome in patients with the Zollinger-Ellison syndrome. New England Journal of Medicine 1986 315 151-158.